Retina Group of Florida
Eduardo Uchiyama, MD, FACS, is an experienced vitreoretinal surgeon and uveitis specialist, currently serving as an Affiliate Assistant Professor at Florida Atlantic University since May 2015. With a comprehensive background in ophthalmology, Uchiyama completed a fellowship in vitreoretinal surgery at UT Southwestern Medical Center and a fellowship in uveitis and ocular immunology at Harvard Medical School. Previous roles include serving as Chief Retina Fellow at Parkland Memorial Hospital and an internal medicine intern at Parkland Hospital. Academic credentials include a Doctor of Medicine (MD) from Universidad de San Martín de Porres in Peru and extensive training throughout various prestigious institutions in the United States.
This person is not in any teams
Retina Group of Florida
Retina Group of Florida is an ophthalmology practice devoted solely to the diagnosis and treatment of disorders of the retina, macula, vitreous, and related structures of the eye. With several convenient locations throughout Broward and Palm Beach Counties, you’re always within close proximity to excellent retinal care. We are dedicated to providing individualized attention and the best care possible – all in a comfortable and compassionate environment. We know how stressful visiting the eye doctor can be, especially when it involves precious vision. That’s why Retina Group of Florida strives to make our patients as comfortable as possible by providing personalized care and advanced information on what to expect during a visit to our offices. The staff of Retina Group of Florida is here to serve. We pride ourselves on providing the same standard of care we would apply to ourselves. For the utmost convenience, many surgical procedures can be performed in our office. Our goal is to help our patients achieve a full and speedy recovery. We get people back to their regular routine as soon as possible. We can handle everything from treating retinal tears, certain retinal detachments, diabetic retinopathy, age-related macular degeneration (AMD), and vitreoretinal diseases to offer complete comprehensive treatment at one location.